109 related articles for article (PubMed ID: 19914733)
1. Expression of Mina53, a novel c-Myc target gene, is a favorable prognostic marker in early stage lung cancer.
Komiya K; Sueoka-Aragane N; Sato A; Hisatomi T; Sakuragi T; Mitsuoka M; Sato T; Hayashi S; Izumi H; Tsuneoka M; Sueoka E
Lung Cancer; 2010 Aug; 69(2):232-8. PubMed ID: 19914733
[TBL] [Abstract][Full Text] [Related]
2. Mina53, a novel c-Myc target gene, is frequently expressed in lung cancers and exerts oncogenic property in NIH/3T3 cells.
Komiya K; Sueoka-Aragane N; Sato A; Hisatomi T; Sakuragi T; Mitsuoka M; Sato T; Hayashi S; Izumi H; Tsuneoka M; Sueoka E
J Cancer Res Clin Oncol; 2010 Mar; 136(3):465-73. PubMed ID: 19756735
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of the myc target gene Mina53 in advanced renal cell carcinoma.
Ishizaki H; Yano H; Tsuneoka M; Ogasawara S; Akiba J; Nishida N; Kojiro S; Fukahori S; Moriya F; Matsuoka K; Kojiro M
Pathol Int; 2007 Oct; 57(10):672-80. PubMed ID: 17803656
[TBL] [Abstract][Full Text] [Related]
4. [Significance of expression of Myc-induced nuclear antigen 53 in hepatocellular carcinoma and its relationship with patient prognosis].
Ye DX; Zhou X; Yang Q; Hu XY; Li H; Xiang FG
Zhonghua Gan Zang Bing Za Zhi; 2020 Mar; 28(3):259-265. PubMed ID: 32306660
[No Abstract] [Full Text] [Related]
5. Mina53, a novel molecular marker for the diagnosis and prognosis of gastric adenocarcinoma.
Xing J; Wang K; Liu PW; Miao Q; Chen XY
Oncol Rep; 2014 Feb; 31(2):634-40. PubMed ID: 24337011
[TBL] [Abstract][Full Text] [Related]
6. Mina53 as a potential prognostic factor for esophageal squamous cell carcinoma.
Tsuneoka M; Fujita H; Arima N; Teye K; Okamura T; Inutsuka H; Koda Y; Shirouzu K; Kimura H
Clin Cancer Res; 2004 Nov; 10(21):7347-56. PubMed ID: 15534111
[TBL] [Abstract][Full Text] [Related]
7. Potential effects of Mina53 on tumor growth in human pancreatic cancer.
Tan XP; Dong WG; Zhang Q; Yang ZR; Lei XF; Ai MH
Cell Biochem Biophys; 2014 Jul; 69(3):619-25. PubMed ID: 24522517
[TBL] [Abstract][Full Text] [Related]
8. Expression of Myc target gene mina53 in subtypes of human lymphoma.
Teye K; Arima N; Nakamura Y; Sakamoto K; Sueoka E; Kimura H; Tsuneoka M
Oncol Rep; 2007 Oct; 18(4):841-8. PubMed ID: 17786344
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical expression of Mina53 and Ki67 proteins in human primary gingival squamous cell carcinoma.
Kuratomi K; Yano H; Tsuneoka M; Sakamoto K; Kusukawa J; Kojiro M
Kurume Med J; 2006; 53(3-4):71-8. PubMed ID: 17317935
[TBL] [Abstract][Full Text] [Related]
10. Twist may be associated with invasion and metastasis of hypoxic NSCLC cells.
Wei L; Sun JJ; Cui YC; Jiang SL; Wang XW; Lv LY; Xie L; Song XR
Tumour Biol; 2016 Jul; 37(7):9979-87. PubMed ID: 26819207
[TBL] [Abstract][Full Text] [Related]
11. RBMS3 is a tumor suppressor gene that acts as a favorable prognostic marker in lung squamous cell carcinoma.
Liang YN; Liu Y; Meng Q; Li X; Wang F; Yao G; Wang L; Fu S; Tong D
Med Oncol; 2015 Feb; 32(2):459. PubMed ID: 25588924
[TBL] [Abstract][Full Text] [Related]
12. Mina53 nuclear localization is an important indicator of prognosis in patients with colorectal cancer after adjuvant chemotherapy.
Fujino S; Kinugasa T; Sudo T; Mizobe T; Yoshida T; Yoshida N; Ohchi T; Tajiri K; Yuge K; Nagasu S; Katagiri M; Akagi Y
Oncol Rep; 2018 Jul; 40(1):101-110. PubMed ID: 29750310
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of 14-3-3γ overexpression in advanced non-small cell lung cancer.
Raungrut P; Wongkotsila A; Lirdprapamongkol K; Svasti J; Geater SL; Phukaoloun M; Suwiwat S; Thongsuksai P
Asian Pac J Cancer Prev; 2014; 15(8):3513-8. PubMed ID: 24870749
[TBL] [Abstract][Full Text] [Related]
14. Prospective study on the diagnosis and prognosis of lung cancer by using new simultaneously observed seromarkers.
Zhang Q; Ren H; Wang B
Ann N Y Acad Sci; 1995 Sep; 768():337-40. PubMed ID: 8526382
[No Abstract] [Full Text] [Related]
15. MicroRNA-184 Deregulated by the MicroRNA-21 Promotes Tumor Malignancy and Poor Outcomes in Non-small Cell Lung Cancer via Targeting CDC25A and c-Myc.
Lin TC; Lin PL; Cheng YW; Wu TC; Chou MC; Chen CY; Lee H
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1532-9. PubMed ID: 25990966
[TBL] [Abstract][Full Text] [Related]
16. 14-3-3ζ/TGFβR1 promotes tumor metastasis in lung squamous cell carcinoma.
Zhao Y; Qiao W; Wang X; Yin H; Cui J; Cui Y; Chen X; Hu J; Lu H; Meng Q; Wang Y; Cai L
Oncotarget; 2016 Dec; 7(50):82972-82984. PubMed ID: 27764818
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical expressions of Cap43 and Mina53 proteins in neuroblastoma.
Fukahori S; Yano H; Tsuneoka M; Tanaka Y; Yagi M; Kuwano M; Tajiri T; Taguchi T; Tsuneyoshi M; Kojiro M
J Pediatr Surg; 2007 Nov; 42(11):1831-40. PubMed ID: 18022432
[TBL] [Abstract][Full Text] [Related]
18. [T1-2N0M0-stage lung cancer, its diagnosis and treatment results].
Perel'man MI; Denisov LE; Odintsov SV
Ter Arkh; 1989; 61(7):128-31. PubMed ID: 2555930
[No Abstract] [Full Text] [Related]
19. Peroxiredoxin 4 as an independent prognostic marker for survival in patients with early-stage lung squamous cell carcinoma.
Hwang JA; Song JS; Yu DY; Kim HR; Park HJ; Park YS; Kim WS; Choi CM
Int J Clin Exp Pathol; 2015; 8(6):6627-35. PubMed ID: 26261544
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of CHD1L is positively associated with metastasis of lung adenocarcinoma and predicts patients poor survival.
He LR; Ma NF; Chen JW; Li BK; Guan XY; Liu MZ; Xie D
Oncotarget; 2015 Oct; 6(31):31181-90. PubMed ID: 26360781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
